Close
Back to mobile site

BTIG Downgrades Biogen (BIIB) to Neutral

March 21, 2019 9:34 AM EDT Send to a Friend
BTIG analyst Thomas Shrader downgraded Biogen (NASDAQ: BIIB) from Buy to Neutral.The analyst comments "Earlier this morning, Biogen announced the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login